Journal of Drugs in Dermatology - Generic norethindrone acetate and ethinyl estradiol for acne vulgaris
February 1, 2008 -- The FDA has recently granted approval for the first generic formulations of norethindrone acetate and ethinyl estradiol tablets (28 day and 21 day)...
American Family Physician - Norethindrone Acetate and Endometrial Hyperplasia
March 1, 2001 -- Results from many epidemiologic studies have shown that unopposed estrogen therapy is associated with a dose-dependent increased risk of endometrial...
American Family Physician - Norethindrone more effective for menses suppression
July 15, 2006 -- Clinical Question: Do oral contraceptives containing norethindrone acetate or levonorgestrel differ in their effect on suppression of menses with...
Chain Drug Review - Breckenridge Pharmaceutical Inc
September 29, 2008 -- BOCA RATON, Fla. -- Breckenridge Pharmaceutical Inc. is a privately held pharmaceutical marketing, research and development company that was founded...
Chain Drug Review - Breckenridge wins FDA O.K
August 4, 2008 -- [ILLUSTRATION OMITTED] BOCA RATON, Fla. -- Breckenridge Pharmaceutical Inc. has been given Food and Drug Administration approval to market...
Chain Drug Review - Breckenridge receives FDA approval
July 14, 2008 -- BOCA RATON, Fla. -- Breckenridge Pharmaceutical Inc. has been given Food and Drug Administration approval to market estradiol/norethindrone acetate...
PR Newswire Europe - Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe.
October 29, 2007 -- FAJARDO, Puerto Rico and CORONA, California, October 29 /PRNewswire/ -- Warner Chilcott Company, Inc. and Watson Pharmaceuticals, Inc....
OB/GYN News - Loestrin 24 Fe for birth control
June 1, 2006 -- Loestrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) is indicated for the prevention of pregnancy. The...
Internal Medicine News - Tablets available for birth control
May 1, 2006 -- Loestrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) is indicated for the prevention of pregnancy. The...
Medical Marketing and Media - Pipeline
April 1, 2006 -- The FDA has approved ImClone Systems and Bristol-Myers Squibb's Erbitux (Cetuximab), an IgG1 monoclonal anti-body, for use in the treatment of...
